In the treatment of ASS1‐deficient cutaneous melanoma, uveal melanoma, and malignant pleural mesothelioma, ADI‐PEG 20 was well tolerated and demonstrated antitumor activity.9, 10, 23, 24. Here, ASS1 is linked to uveal melanoma.